Organ-on-a-chip for studying immune cell adhesion to liver sinusoidal endothelial cells: the potential for testing immunotherapies and cell therapy trafficking
Immunotherapy has changed the landscape of treatment options for patients with
hepatocellular cancer. Checkpoint inhibitors are now standard of care for patients with …
hepatocellular cancer. Checkpoint inhibitors are now standard of care for patients with …
Research progress on the correlation between acetaldehyde dehydrogenase 2 and hepatocellular carcinoma development
D Yang, Y Hu, J Yang, L Tao, Y Su, Y Wu, Y Yao… - … of Pharmacology and …, 2024 - ASPET
Hepatocellular carcinoma (HCC) is the predominant pathologic type of primary liver cancer.
It is a malignant tumor of liver epithelial cells. There are many ways to treat HCC, but the …
It is a malignant tumor of liver epithelial cells. There are many ways to treat HCC, but the …
Mechanisms of Sorafenib Resistance in Hepatocellular Carcinoma
Y Liang - Clinics and Research in Hepatology and …, 2024 - Elsevier
Liver cancer is one of the most common and devastating causes of cancer-related deaths
worldwide. Hepatocellular carcinoma (HCC) accounts for approximately 90% of primary liver …
worldwide. Hepatocellular carcinoma (HCC) accounts for approximately 90% of primary liver …
[HTML][HTML] Assessment of Albumin-Incorporating Scores at Hepatocellular Carcinoma Diagnosis Using Machine Learning Techniques: An Evaluation of Prognostic …
M Suárez, P Martínez-Blanco, S Gil-Rojas, AM Torres… - Bioengineering, 2024 - mdpi.com
Hepatocellular carcinoma (HCC) presents high mortality rates worldwide, with limited
evidence on prognostic factors at diagnosis. This study evaluates the utility of common …
evidence on prognostic factors at diagnosis. This study evaluates the utility of common …
Image-guided High-Dose-Rate Brachytherapy for Hepatocellular Carcinoma Could Be the Ultimate Ablation Tool
J Chapiro - Radiology, 2024 - pubs.rsna.org
Dr Julius Chapiro is an associate professor in radiology, hepatology, and biomedical
engineering at the Yale University School of Medicine and the principal investigator of the …
engineering at the Yale University School of Medicine and the principal investigator of the …
CBX1 is involved in hepatocellular carcinoma progression and resistance to sorafenib and lenvatinib via IGF-1R/AKT/SNAIL signaling pathway
SS Zheng, JF Wu, WX Wu, JW Hu, D Zhang… - Hepatology …, 2024 - Springer
Abstract Background Chromobox Homolog 1 (CBX1) plays a crucial role in the
pathogenesis of numerous diseases, including the evolution and advancement of diverse …
pathogenesis of numerous diseases, including the evolution and advancement of diverse …
From MASLD to HCC: what's in the middle?
Metabolic dysfunction associated steatotic liver disease (MASLD) is a progressive
pathological condition characterized by the accumulation of triglycerides within hepatocytes …
pathological condition characterized by the accumulation of triglycerides within hepatocytes …
Histamine-related genes participate in the establishment of an immunosuppressive microenvironment and impact the immunotherapy response in hepatocellular …
X Zhang, P Zheng, B Meng, H Zhuang, B Lu… - Clinical and …, 2024 - Springer
Chronic inflammation is pivotal in the pathogenesis of hepatocellular carcinoma (HCC).
Histamine is a biologically active substance that amplifies the inflammatory and immune …
Histamine is a biologically active substance that amplifies the inflammatory and immune …
[HTML][HTML] Quantifying the natural growth rate of hepatocellular carcinoma: A real-world retrospective study in southwestern China
L Tu, H Xie, Q Li, PG Lei, PL Zhao, F Yang… - World Journal of …, 2024 - ncbi.nlm.nih.gov
BACKGROUND In recent years, approximately half of the newly diagnosed cases and
mortalities attributed to hepatocellular carcinoma (HCC) have been reported in China …
mortalities attributed to hepatocellular carcinoma (HCC) have been reported in China …
[HTML][HTML] Androgen-Induced, β-Catenin-Activated Hepatocellular Adenomatosis with Spontaneous External Rupture
J Huang, T Ali, DM Feldman, ND Theise - Diagnostics, 2024 - mdpi.com
Androgens have long been recognized as oncogenic agents. They can induce both benign
and malignant hepatocellular neoplasms, including hepatocellular adenoma (HCA) and …
and malignant hepatocellular neoplasms, including hepatocellular adenoma (HCA) and …